For the first time, we also showed that anti-CTLA4 therapy cures most of the animals with idMMR neuroblastoma tumors and induces a long-term immune memory response with epitope spreading that allows for a highly effective anti-tumor response against both idMMR and pMMR neuroblastoma tumors upon rechallenge. The gene discussed is CTLA4; the disease is neuroblastoma.